Levetiracetam Sustained-release Granules(Hangzhou Bio-Sincerity Pharma)

左乙拉西坦缓释颗粒(杭州百诚医药)

Report date: 2025/09/23 09:51:59

Base Information

Drug NameLevetiracetam Sustained-release Granules(Hangzhou Bio-Sincerity Pharma)
Drug Alias Name左旋乙拉西坦左乙拉西坦缓释颗粒(2.2改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicle glycoprotein 2A modulators
TargetsSynaptic vesicle glycoprotein 2A
Therapy Area/IndicationsEpilepsies, Partial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsEpilepsies, Partial
Inactive IndicationsN/A

Other Information

ATC CodeN/A